Well, the concept of cerebral collateral cascade was driven to explain that collaterals have a different impact on ischemic tissue from arterial to tissue level to venous drainage sites. And our project was to realize an advanced evaluation of these parameters by considering multi-phase CT angiography instead of single-phase CT angiography in the evaluation of arterial collaterals, to use HAR, Hypoperfusion Intensity Ratio, to assess tissue-level collaterals and the comprehensive venous outflow instead of conventional cortical venous opacification score to assess the drainage pathways...
Well, the concept of cerebral collateral cascade was driven to explain that collaterals have a different impact on ischemic tissue from arterial to tissue level to venous drainage sites. And our project was to realize an advanced evaluation of these parameters by considering multi-phase CT angiography instead of single-phase CT angiography in the evaluation of arterial collaterals, to use HAR, Hypoperfusion Intensity Ratio, to assess tissue-level collaterals and the comprehensive venous outflow instead of conventional cortical venous opacification score to assess the drainage pathways. The most important discovery of our work is that patients that have at least two different kinds of collaterals, from the arterial and venous side or tissue level and arterials or tissue level and venous side, are those that could benefit the most from endovascular thrombectomy and reperfusion therapies. The point is that evaluating these collaterals, all these collaterals in a rapid set, that is in an emergency setting, that is the stroke care, is difficult to address. But we think that with the involvement of artificial intelligence, some platforms can be interested in developing our concept and realizing a one-time evaluation of those collaterals to make it easy to assess all collaterals and have practical instruments to refine patient selection for reperfusion therapies that could help physicians in identifying those subjects that, based on their infarct growth rate, are capable of reaching better outcomes and less infarct volume after treatment.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.